HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$2.43
Day range
$2.02 - $2.35
Year range
$1.40 - $18.00
Market cap
6.14M USD
Avg Volume
2.88M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.47M | -57.42% |
Net income | -2.40M | 81.52% |
Net profit margin | — | — |
Earnings per share | -8.14 | -16.29% |
EBITDA | -2.47M | 55.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.71M | -27.64% |
Total assets | 5.79M | -32.87% |
Total liabilities | 797.48K | -30.60% |
Total equity | 4.99M | — |
Shares outstanding | 2.86M | — |
Price to book | 0.63 | — |
Return on assets | -89.03% | — |
Return on capital | -98.94% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.40M | 81.52% |
Cash from operations | -2.12M | 14.96% |
Cash from investing | 0.00 | — |
Cash from financing | -30.61K | 42.89% |
Net change in cash | -2.15M | 15.54% |
Free cash flow | 48.52K | 105.63% |
About
Founded
2011
Headquarters
Website
Employees
13